Membership
NLA Education and Training
Lipid Scholarship Program
LipidSpin
JCL
Find a Member

Features


April 1, 2024

New Scientific Statement - Update to the Use of Lp(a) in Clinical Practice

The Scientific Statement provides an updated understanding of whom should have Lp(a) levels measured, how to interpret...

Read More...

November 14, 2023

NLA 2024 Nominations Open

Nominations open November 15, 2023 for the National Lipid Association Board of Directors and Chapter officers and will...

Read More...

September 29, 2023

Ionis announces positive olezarsen topline results from Phase 3 study in people with familial chylomicronemia syndrome

Ionis announced positive topline results for the Phase 3 Balance study of olezarsen in people with familial...

Read More...

September 5, 2023

NLA Responds to the USPSTF Recommendation Statement on Screening Lipid Panel in Children and Adolescents

The United States Preventive Services Task Force (USPSTF) recently released its Final Recommendation Statement on...

Read More...

July 13, 2023

Novartis Receives FDA Approval for Label Update On Use of Leqvio (Inclisiran)

Novartis received FDA approval for a label update that will allow for use of Leqvio ® (inclisiran) in certain patients...

Read More...